M. Baigent et al., SELF-REPORTS OF THE INTERACTION BETWEEN SUBSTANCE-ABUSE AND SCHIZOPHRENIA, Australian and New Zealand Journal of Psychiatry, 29(1), 1995, pp. 69-74
Fifty-three psychiatric hospital inpatients with a dual diagnosis of s
ubstance abuse and schizophrenia were given the Brief Symptom Inventor
y and the Schizophrenia/Substance Abuse Interview Schedule. Mean age w
as 29; 49 were men. Only 11% were employed. Forty percent abused mainl
y alcohol, 40% cannabis and 8% amphetamines; 20% abused more than one
substance. Mean onset age of drug abuse was 16 years; schizophrenia wa
s diagnosed a mean of 5 years later, and subjects had been admitted to
hospital an average of 7 times since then. Most believed that drug ab
use initiated or exacerbated their schizophrenia; 80% took drugs prima
rily to relieve dysphoria and anxiety. Amphetamines improved subjectiv
e well-being significantly more than alcohol, but choice of drugs was
determined mainly by price and availability. Only cannabis increased p
ositive symptoms of schizophrenia and only amphetamines reduced negati
ve ones. Effectively treating this population requires an integration
of psychiatric and drug treatment services, ideally in a community con
text.